Literature DB >> 11520424

Biomarkers in disease and health.

F Branca1, A B Hanley, B Pool-Zobel, H Verhagen.   

Abstract

Biomarkers have considerable potential in aiding the understanding of the relationship between diet and disease or health. However, to assess the role, relevance and importance of biomarkers on a case by case basis it is essential to understand and prioritise the principal diet and health issues. In the majority of cases, dietary compounds are only weakly biologically active in the short term, have multiple targets and can be both beneficial and deleterious. This poses particular problems in determining the net effect of types of foods on health. In principle, a biomarker should be able to contribute to this debate by allowing the measurement of exposure and by acting as an indicator either of a deleterious or of an enhanced health effect prior to the final outcome. In this review, the examples chosen - cancer (stomach, colon/rectal, breast); coronary heart disease and osteoporosis - reflect three major diet-related disease issues. In each case the onset of the disease has a genetic determinant which may be exacerbated or delayed by diet. Perhaps the most important factor is that in each case the disease, once manifest, is difficult to influence in a positive way by diet alone. This then suggests that the emphasis for biomarker studies should focus on predictive biomarkers which can be used to help in the development of dietary strategies which will minimise the risk and be of greater benefit.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11520424     DOI: 10.1079/bjn2001339

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  8 in total

1.  A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)--Potsdam Study cohort.

Authors:  C Heidemann; K Hoffmann; J Spranger; K Klipstein-Grobusch; M Möhlig; A F H Pfeiffer; H Boeing
Journal:  Diabetologia       Date:  2005-05-12       Impact factor: 10.122

2.  Meta-analysis of untargeted metabolomic data from multiple profiling experiments.

Authors:  Gary J Patti; Ralf Tautenhahn; Gary Siuzdak
Journal:  Nat Protoc       Date:  2012-02-16       Impact factor: 13.491

3.  Associations between dietary habits and body mass index with gut microbiota composition and fecal water genotoxicity: an observational study in African American and Caucasian American volunteers.

Authors:  Volker Mai; Quintece M McCrary; Rashmi Sinha; Michael Glei
Journal:  Nutr J       Date:  2009-10-21       Impact factor: 3.271

4.  Modulation of detoxification enzymes by watercress: in vitro and in vivo investigations in human peripheral blood cells.

Authors:  Thomas Hofmann; A Kuhnert; A Schubert; C Gill; I R Rowland; B L Pool-Zobel; M Glei
Journal:  Eur J Nutr       Date:  2009-07-28       Impact factor: 5.614

5.  TGF-alpha expression as a potential biomarker of risk within the normal-appearing colorectal mucosa of patients with and without incident sporadic adenoma.

Authors:  Carrie R Daniel; Roberd M Bostick; William Dana Flanders; Qi Long; Veronika Fedirko; Eduard Sidelnikov; March E Seabrook
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

6.  Intervention with cloudy apple juice results in altered biological activities of ileostomy samples collected from individual volunteers.

Authors:  Selvaraju Veeriah; Kamal Kumar Balavenkatraman; Frank- D Böhmer; Kathrin Kahle; Michael Glei; Elke Richling; Wolfgang Scheppach; Beatrice L Pool-Zobel
Journal:  Eur J Nutr       Date:  2008-07-17       Impact factor: 5.614

7.  Vegetables and fruit intake and cancer mortality in the Hiroshima/Nagasaki Life Span Study.

Authors:  C Sauvaget; J Nagano; M Hayashi; E Spencer; Y Shimizu; N Allen
Journal:  Br J Cancer       Date:  2003-03-10       Impact factor: 7.640

Review 8.  The controversial role of Enterococcus faecalis in colorectal cancer.

Authors:  Carolina Vieira de Almeida; Antonio Taddei; Amedeo Amedei
Journal:  Therap Adv Gastroenterol       Date:  2018-06-26       Impact factor: 4.409

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.